Table 3.
Changes of perfusion pressure (ΔPP [mmHg]) in the mesenteric artery induced by norepinephrine and potassium chloride injections.
| The pharmaceutical in injection (dose): | SHR-SL Mean ± SEM | SHR-C Mean ± SEM | WKY-SL Mean ± SEM | WKY-C Mean ± SEM |
|---|---|---|---|---|
| Norepinephrine (0.01 μg) | 8.63* ± 1.58 | 26.47 ± 9.15 | 15.00 ± 3.73 | 21.18 ± 4.81 |
| Norepinephrine (0.10 μg) | 47.33* ± 7.70 | 77.80 ± 6.06 | 35.14 ± 5.71 | 38.77 ± 6.65 |
| Norepinephrine (0.50 μg) | 85.80* ± 12.07 | 151.60 ± 8.78 | 70.27 ± 9.03 | 66.50 ± 9.51 |
| Norepinephrine (1.00 μg) | 96.43* ± 14.21 | 189.97 ± 8.91 | 88.23 ± 9.95 | 80.00 ± 11.29 |
| Norepinephrine (3.00 μg) | 109.40* ± 16.54 | 203.83 ± 9.17 | 98.05 ± 13.72 | 91.14 ± 12.44 |
| Norepinephrine (5.00 μg) | 118.33* ± 17.62 | 204.47 ± 7 0.41 | 102.73 ± 13.87 | 84.95 ± 11.56 |
| KCl 10.5 mg/ml | 43.03* ± 4.36 | 56.93 ± 3.85 | 26.45 ± 3.45 | 35.36 ± 4.58 |
ΔPP for SHR treated with egg-lecithin (SHR-SL; n = 15), SHR not treated control group (SHR-C; n = 15), WKY treated with egg-lecithin (WKY-SL; n = 11) and WKY not treated control group (WKY-C; n = 11). *P < 0.05, compared to the control group (SL vs. C).